+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Veterinary Antibiotics Global Market Report 2020

  • ID: 4856016
  • Report
  • November 2019
  • Region: Global
  • 200 pages
  • The Business Research Company
1 of 5

FEATURED COMPANIES

  • Bayer AG
  • Boehringer Ingelheim GmbH
  • Elanco
  • Huvepharma AD
  • Novartis Animal Health
  • Phibro Animal Health Corp
  • MORE
Veterinary Antibiotics Market Global Report 2020 from the author provides strategists, marketers and senior management with the critical information they need to assess the global veterinary antibiotics market.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Description:
Where is the largest and fastest growing market for the veterinary antibiotics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Veterinary Antibiotics Market Global Report from the author answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market
  • The Market Characteristics section of the report defines and explains the market.
  • The Market Size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market Segmentations break down market into sub markets.
  • The Regional and Country section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive Landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The Trends and Strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
Scope
  • Markets Covered: 1) By Product: Anti-parasitic, Anti-bacterial, Non-steroidal anti-inflammatory drug, Others 2) By End User: Farm Animals , Companion Animals 3) By Administration: Premixes, Injections, Oral Powders, Oral Solutions, Others
  • Companies Mentioned: Bayer AG, Boehringer Ingelheim GmbH, Ceva Sante Animale, Eli Lilly Company, Elanco
  • Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA
  • Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
  • Time Series: Five years historic and forecast.
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Bayer AG
  • Boehringer Ingelheim GmbH
  • Elanco
  • Huvepharma AD
  • Novartis Animal Health
  • Phibro Animal Health Corp
  • MORE
1. Executive Summary

2. Veterinary Antibiotics Market Characteristics

3. Veterinary Antibiotics Market Size And Growth
3.1. Global Veterinary Antibiotics Historic Market, 2015 - 2019, $ Billion
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
3.2. Global Veterinary Antibiotics Forecast Market, 2019 - 2022F, 2025F, 2030F, $ Billion
3.2.1. Drivers Of The Market
3.2.2. Restraints On the Market

4. Veterinary Antibiotics Market Segmentation
4.1. Global Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Anti-parasitic Anti-bacterial
  • Non-steroidal anti-inflammatory drug Others
4.2. Global Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Farm Animals Companion Animals
4.3. Global Veterinary Antibiotics Market, Segmentation By Administration, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Premixes Injections
  • Oral Powders Oral Solutions
  • Others
5. Veterinary Antibiotics Market Regional And Country Analysis
5.1. Global Veterinary Antibiotics Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
5.2. Global Veterinary Antibiotics Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

6. Asia-Pacific Veterinary Antibiotics Market
6.1. Asia-Pacific Veterinary Antibiotics Market Overview
6.2. Asia-Pacific Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
6.3. Asia-Pacific Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

7. China Veterinary Antibiotics Market
7.1. China Veterinary Antibiotics Market Overview
7.2. China Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion
7.3. China Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion

8. India Veterinary Antibiotics Market
8.1. India Veterinary Antibiotics Market Overview
8.2. India Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
8.3. India Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

9. Japan Veterinary Antibiotics Market
9.1. Japan Veterinary Antibiotics Market Overview
9.2. Japan Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
9.3. Japan Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

10. Australia Veterinary Antibiotics Market
10.1. Australia Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
10.2. Australia Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

11. Indonesia Veterinary Antibiotics Market
11.1. Indonesia Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
11.2. Indonesia Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

12. South Korea Veterinary Antibiotics Market
12.1. South Korea Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
12.2. South Korea Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

13. Western Europe Veterinary Antibiotics Market
13.1. Western Europe Veterinary Antibiotics Market Overview
13.2. Western Europe Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
13.3. Western Europe Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

14. UK Veterinary Antibiotics Market
14.1. UK Veterinary Antibiotics Market Overview
14.2. UK Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
14.3. UK Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

15. Germany Veterinary Antibiotics Market
15.1. Germany Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
15.2. Germany Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

16. France Veterinary Antibiotics Market
16.4. France Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
16.5. France Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

17. Eastern Europe Veterinary Antibiotics Market
17.1. Eastern Europe Veterinary Antibiotics Market Overview
17.2. Eastern Europe Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
17.3. Eastern Europe Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

18. Russia Veterinary Antibiotics Market
18.1. Russia Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
18.2. Russia Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

19. North America Veterinary Antibiotics Market
19.1. North America Veterinary Antibiotics Market Overview
19.2. North America Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
19.3. North America Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

20. USA Veterinary Antibiotics Market
20.1. USA Veterinary Antibiotics Market Overview
20.2. USA Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
20.3. USA Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

21. South America Veterinary Antibiotics Market
21.1. South America Veterinary Antibiotics Market Overview
21.2. South America Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
21.3. South America Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

22. Brazil Veterinary Antibiotics Market
22.1. Brazil Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
22.2. Brazil Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

23. Middle East Veterinary Antibiotics Market
23.1. Middle East Veterinary Antibiotics Market Overview
23.2. Middle East Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
23.3. Middle East Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

24. Africa Veterinary Antibiotics Market
24.1. Africa Veterinary Antibiotics Market Overview
24.2. Africa Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
24.3. Africa Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

25. Veterinary Antibiotics Market Competitive Landscape And Company Profiles
25.1. Veterinary Antibiotics Market Competitive Landscape
25.2. Veterinary Antibiotics Market Company Profiles
25.2.1. Bayer AG
25.2.1.1. Overview
25.2.1.2. Products and Services
25.2.1.3. Strategy
25.2.1.4. Financial Performance
25.2.2. Boehringer Ingelheim GmbH
25.2.2.1. Overview
25.2.2.2. Products and Services
25.2.2.3. Strategy
25.2.2.4. Financial Performance
25.2.3. Ceva Sante Animale
25.2.3.1. Overview
25.2.3.2. Products and Services
25.2.3.3. Strategy
25.2.3.4. Financial Performance
25.2.4. Eli Lilly Company
25.2.4.1. Overview
25.2.4.2. Products and Services
25.2.4.3. Strategy
25.2.4.4. Financial Performance
25.2.5. Elanco
25.2.5.1. Overview
25.2.5.2. Products and Services
25.2.5.3. Strategy
25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Veterinary Antibiotics Market

27. Veterinary Antibiotics Market Trends And Strategies

28. Veterinary Antibiotics Market Future Outlook and Potential Analysis

29. Appendix
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Bayer AG
  • Boehringer Ingelheim GmbH
  • Elanco
  • Huvepharma AD
  • Novartis Animal Health
  • Phibro Animal Health Corp
  • MORE
The veterinary antibiotics market consists of sales of veterinary antibiotics and related services. Veterinary antibiotics are used to fight against infections and diseases in animals caused due to bacteria. Veterinary antibiotics industry includes companies involved in the production of antibiotics used for therapeutic and prophylaxis treatment of animals.

The global veterinary antibiotics market was valued at about $2.54 billion in 2018 and is expected to grow to $2.95 billion at a CAGR of 3.8% through 2022.

North America was the largest region in the veterinary antibiotics market in 2017. This region is expected to remain the largest during the next five years. The veterinary antibiotics market in Asia Pacific is forecasted to register the highest CAGR during 2018-2023.

Increase in the number of zoonotic diseases is driving the veterinary antibiotics market. Zoonotic diseases are infectious diseases caused by microscopic organisms, infections, and parasites that spread between animals and humans. Two of the most common zoonotic pathogens salmonella and campylobacter are present in the intestines of these animals. Zoonotic diseases are also a potential threat to humans as they get transferred through the food chain. A study conducted by the FoodNet (Centers for Disease Control and Prevention, USA) in 2017 found that 24,484 foodborne illnesses, 5,677 hospitalizations, and 122 deaths are caused due to zoonotic diseases. In addition, highest incidences per 100,000 population in the USA are caused due to infectious diseases such as campylobacter, salmonella, and shigella. Therefore, there is a need to diagnose these diseases in animals at an early stage, which is a major driver of the veterinary antibiotics market.

Rising threat of antibiotic resistance is a major restraint for the veterinary antibiotics market. Antibiotic resistance in animals is the ability of a microbe to withstand the impact of an antibiotic that once could successfully treated the infection from the same type of microbe. This can be a result of using antibiotics more than prescribed limit. In this regard, the European Union (EU) has approved various restrictions on veterinary antibiotics including ban of antibiotics for animals and prohibiting the usage of antimicrobials in food, which is restricting the growth of the veterinary antibiotics market.

Increasing collaboration between companies is an emerging trend in the veterinary antibiotics market. This is mainly because collaborations offer companies combined technologies and a wider and more diversified portfolio of products to work with. The collaborations also improve the quality of the antibiotics and the speed at which they are produced. Therefore, companies in the veterinary antibiotics market are focusing on collaborations. For example, in April 2019, Bayer AG entered into a strategic collaboration with Adiva GmbH to develop therapeutic antibodies for veterinary medicine.

The veterinary antibiotics prescription drugs market is regulated by Section 503(f) of the Food, Drug and Cosmetic Act of FDA. According to this law, the veterinary antibiotics drug labels are mandated to include a caution statement which states that these drugs can only be used with the permission of a licensed veterinarian. The sale and use of antibiotics prescription drugs without a prescription is usually reported to the FDA and a strict action is taken based on it. Hence, regulations such as these would regulate veterinary antibiotics manufacturers and sellers.

Major players in the market are Bayer AG, Boehringer Ingelheim GmbH, Ceva Sante Animale, Eli Lilly Company and Elanco.
Note: Product cover images may vary from those shown
5 of 5
  • Bayer AG
  • Boehringer Ingelheim GmbH
  • Ceva Sante Animale
  • Eli Lilly Company
  • Elanco
  • Merck & Co
  • Sanofi
  • Virbac
  • Zoetis
  • Crystal Pharma
  • Dechra Pharmaceuticals PLC
  • Huvepharma AD
  • Vetoquinol S.A
  • Merial (Animal Health Division Of Sanofi)
  • Novartis Animal Health
  • Phibro Animal Health Corp
  • Bioniche Animal Health
  • Fort Dodge Animal Health
  • Pfizer Inc
  • Perrigo
  • IDEXX laboratories
  • BioPredic International
  • Sparhawk laboratories
  • Stason Pharmaceuticals
  • Vedco Inc
Note: Product cover images may vary from those shown
6 of 5

Loading
LOADING...

Adroll
adroll